Nanjing Well Pharmaceutical Group (603351.SH) executive Zou Jianguo reduced his shareholding by 9300 shares.

Zhitong Finance · Sep 12 17:17

Well Pharmaceutical (603351.SH) issued an announcement. As of September 11, 2024, the schedule for this holdings reduction plan...

According to the Zhitong Finance App, Weil Pharmaceutical (603351.SH) issued an announcement. As of September 11, 2024, the current holdings reduction plan has expired, and company executive Zou Jianguo has reduced his holdings of 9,300 shares through centralized bidding transactions.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

威尔药业(603351.SH)高管邹建国减持9300股

Nanjing Well Pharmaceutical Group (603351.SH) executive Zou Jianguo reduced his shareholding by 9300 shares.

Risk Disclaimer

Statement